Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2014; 20(42): 15941-15942
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15941
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15941
Clinical importance of serum procalcitonin in ulcerative colitis patients
Ergenekon Karagoz, Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital, Istanbul 34668, Turkey
Alpaslan Tanoglu, Department of Gastroenterology, GATA Haydarpasa Training Hospital, Istanbul 34668, Turkey
Author contributions: Both authors contributed equally to this manuscript.
Correspondence to: Alpaslan Tanoglu, MD, Gastroenteorologist, Department of Gastroenterology, GATA Haydarpasa Training Hospital, Tibbiye Street, Istanbul 34668, Turkey. alpaslantanoglu@yahoo.com
Telephone: +90-216-5422020 Fax: +90-216-5422007
Received: March 15, 2014
Revised: May 31, 2014
Accepted: June 14, 2014
Published online: November 14, 2014
Processing time: 246 Days and 21.9 Hours
Revised: May 31, 2014
Accepted: June 14, 2014
Published online: November 14, 2014
Processing time: 246 Days and 21.9 Hours
Core Tip
Core tip: In a recently published article entitled “Clinical significance of serum procalcitonin in patients with ulcerative colitis”, Koido et al investigated the association of procalcitonin with ulcerative colitis (UC) activity. They concluded that elevated procalcitonin levels were significantly correlated with UC activity. We would like to thank the authors for their comprehensive contribution.